Found 20 matching trials
Conjugate Vaccine Against Meningococcus C a Brazilian Project
PHASE2TYPE / DESIGN STUDY: Clinical trial phase II / III, randomized, double-blin...
Location
• Unidade de Ensaios Clínicos para Imunobiológicos/Instituto de Tecnologia em Imunobiológicos de Bio-Manguinhos/Fiocruz
Meningococcal Serogroup ACYWX Conjugate Vaccine in Comparison With MenACWY-TT Conjugate Vaccine
PHASE3Infants aged 9 months will be randomized to receive a meningococcal vaccine...
Location
Centre pour le Developpement des Vaccins du Mali
Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005)
PHASE3This is a study to assess the safety, tolerability, and immunogenicity of V...
Location
Multiple Locations
Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines
PHASE2This study is evaluating the safety and immunogenicity of Hib-MenCY-TT vacc...
Location
GSK Investigational Site
Vaccines Against Salmonella Typhi
PHASE2Using an established model of human typhoid infection, whereby healthy adul...
Location
Centre for Clinical Vaccinology and Tropical Medicine
Study to Assess Immunegnicity & Safety of Pentavalent Meningococcal Vaccine (NmCV-5)
PHASE3This observer-blind, randomized, active controlled trial will be conducted ...
Location
Centre pour le Développement des Vaccins du Mali, ex-Institut Marchoux, Ministry of Health, BP251
Study of Meninigococcal Conjugate Vaccine Containing Serogroups A,C,Y,W and X (MCV5) in Healthy Adults
PHASE1The primary objective of this study is to evaluate the safety of adjuvanted...
Location
Center for Vaccine Development
A Phase I, Randomized, Modified Single-blind, Active-controlled (Infants Only), Four-stage, Step-down, Comparative, Multi-center Study
PHASE1The study will include groups of adults, toddlers, and infants who will rec...
Location
Multiple Locations
Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine
PHASE3This study evaluates the immunogenicity and consistency of 3 Hib-MenCY-TT v...
Location
GSK Investigational Site
Immune Response to Rotavirus Vaccine After a Supplemental Dose Given at 9 Months of Age With Local EPI Vaccines in Mali
PHASE4This study is an evaluation of the immune response to pentavalent rotavirus...